{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:54:57Z","timestamp":1772639697880,"version":"3.50.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1053\/j.seminoncol.2020.02.005","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T18:55:17Z","timestamp":1582570517000},"page":"40-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Recent advances and future directions in the management of the immunocompromised host"],"prefix":"10.1053","volume":"47","author":[{"given":"Konrad","family":"Bochennek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Luckowitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lehrnbecher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2020.02.005_bib0001","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/00043426-199709000-00001","article-title":"Therapy-induced alterations in host defense in children receiving chemotherapy","volume":"19","author":"Lehrnbecher","year":"1997","journal-title":"J Ped Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0002","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infections in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0003","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1200\/JCO.19.00570","article-title":"Long-Term Risk of Infections After Treatment of Childhood Leukemia: A Population-Based Cohort Study Using Administrative Health Data","volume":"37","author":"Pelland-Marcotte","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0004","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0959-8049(01)00274-X","article-title":"Incidence of septicaemias and invasive mycoses in children undergoing treatment for solid tumours: a 12-year experience at a single Italian institution","volume":"37","author":"Haupt","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0005","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1038\/bcj.2015.110","article-title":"Infectious complications in children with acute myeloid leukemia: decreased mortality in multicenter trial AML-BFM 2004","volume":"6","author":"Bochennek","year":"2016","journal-title":"Blood Cancer Journal"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0006","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jinf.2019.06.008","article-title":"Differential risk of severe infection in febrile neutropenia among children with blood cancer or solid tumor","volume":"79","author":"Delebarre","year":"2019","journal-title":"J Infect"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0007","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/sj.leu.2403188","article-title":"Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93","volume":"18","author":"Lehrnbecher","year":"2004","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0008","article-title":"Age-dependent determinants of infectious complications profile in children and adults after hematopoietic cell transplantation: lesson from the nationwide study","author":"Czyzewski","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0009","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000353758","article-title":"Gene Expression Profiling to Predict Viridans Group Streptococcal and Invasive Fungal Infection in Pediatric Acute Myeloid Leukemia: A Brief Report from the Children's Oncology Group","volume":"131","author":"Lee","year":"2013","journal-title":"Acta Haematol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0010","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41375-019-0388-x","article-title":"Infections associated with immunotherapeutic and molecular targeted agents in hematology and oncology. A position paper by the European Conference on Infections in Leukemia (ECIL)","volume":"33","author":"Maschmeyer","year":"2019","journal-title":"Leukemia"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0011","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ejca.2011.01.021","article-title":"Time for paediatric febrile neutropenia guidelines - children are not little adults","volume":"47","author":"Sung","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0012","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1200\/JCO.2012.42.7161","article-title":"Guideline for the management of fever and neutropenia in children with cancer and\/or undergoing hematopoietic stem-cell transplantation","volume":"30","author":"Lehrnbecher","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0013","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1470-2045(14)70017-8","article-title":"Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis, prevention, and treatment of invasive fungal diseases in paediatric patients with cancer or allogeneic haemopoietic stem-cell transplantation","volume":"15","author":"Groll","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0014","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1200\/JCO.2016.71.7017","article-title":"Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update","volume":"35","author":"Lehrnbecher","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0015","first-page":"736","article-title":"No antibiotics for selected febrile neutropenic cancer patients might be safe and feasible [abstract]","volume":"22","author":"Oude Nijhuis","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0016","article-title":"Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer","volume":"1","author":"Stern","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0017","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cmi.2016.11.001","article-title":"Efficacy and safety of withholding antimicrobial treatment in children with cancer, fever and neutropenia, with a demonstrated viral respiratory infection: a randomized clinical trial","volume":"23","author":"Santolaya","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0018","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.cmi.2019.05.019","article-title":"Escmid-ecmm guideline: diagnosis and management of invasive aspergillosis in neonates and children","volume":"25","author":"Warris","year":"2019","journal-title":"Clin Microb Infect"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0019","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1365-2141.2012.09156.x","article-title":"A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children","volume":"158","author":"Caselli","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0020","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1086\/597395","article-title":"Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial","volume":"48","author":"Cordonnier","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0021","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3324\/haematol.2011.042598","article-title":"The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project","volume":"96","author":"Pagano","year":"2011","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0022","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/jac\/dky244","article-title":"Efficacy of pre-emptive versus empirical antifungal therapy in children with cancer and high-risk febrile neutropenia: a randomized clinical trial","volume":"73","author":"Santolaya","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0023","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-4939-6515-1_3","article-title":"Current Algorithms in Fungal Diagnosis in the Immunocompromised Host","volume":"1508","author":"Lehrnbecher","year":"2017","journal-title":"Methods Mol Biol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0024","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0025","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1200\/JCO.2002.07.004","article-title":"Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients","volume":"20","author":"Herbrecht","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0026","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1093\/cid\/ciw592","article-title":"Galactomannan, beta-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis","volume":"63","author":"Lehrnbecher","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0027","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"12","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0028","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/INF.0b013e31818f0934","article-title":"The role of bronchoalveolar lavage galactomannan in the diagnosis of pediatric invasive aspergillosis","volume":"28","author":"Desai","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0029","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/ppul.22670","article-title":"Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan","volume":"48","author":"de Mol","year":"2013","journal-title":"Pediatr Pulmonol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0030","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/jac\/dks208","article-title":"Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies","volume":"67","author":"Reinwald","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0031","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1128\/JCM.02913-15","article-title":"Diagnostic Performance of Galactomannan Antigen Testing in Cerebrospinal Fluid","volume":"54","author":"Chong","year":"2016","journal-title":"J Clin Microbiol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0032","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jpids\/piv014","article-title":"(1\u2013>3)-beta-d-Glucan in Cerebrospinal Fluid as a Biomarker for Candida and Aspergillus Infections of the Central Nervous System in Pediatric Patients","volume":"5","author":"Salvatore","year":"2016","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0033","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1200\/JCO.1999.17.3.796","article-title":"Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography","volume":"17","author":"Heussel","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0034","doi-asserted-by":"crossref","first-page":"e1286","DOI":"10.1542\/peds.2007-2117","article-title":"Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases","volume":"121","author":"Burgos","year":"2008","journal-title":"Pediatrics"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0035","doi-asserted-by":"crossref","first-page":"695","DOI":"10.17219\/acem\/68292","article-title":"Low-dose computed tomography in assessment of pulmonary abnormalities in children with febrile neutropenia suffering from malignant diseases","volume":"26","author":"Zaleska-Dorobisz","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0036","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/pbc.25091","article-title":"Computed tomography guided percutaneous lung biopsies and suspected fungal infections in pediatric cancer patients","volume":"61","author":"Kropshofer","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0037","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1200\/JCO.2014.58.0480","article-title":"Bronchoalveolar lavage and lung biopsy in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review and meta-analysis","volume":"33","author":"Chellapandian","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0038","doi-asserted-by":"crossref","first-page":"e27806","DOI":"10.1002\/pbc.27806","article-title":"Invasive mold disease of the central nervous system in children and adolescents with cancer or undergoing hematopoietic stem cell transplantation: Analysis of 29 contemporary patients","author":"Lauten","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0039","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1128\/JCM.01682-16","article-title":"Prospective Biomarker Screening for Diagnosis of Invasive Aspergillosis in High-Risk Pediatric Patients","volume":"55","author":"Loeffler","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0040","doi-asserted-by":"crossref","first-page":"e13641","DOI":"10.1111\/ctr.13641","article-title":"The early diagnostic value of serum galactomannan antigen test combined with chest computed tomography for invasive pulmonary aspergillosis in pediatric patients after hematopoietic stem cell transplantation","volume":"33","author":"Qiu","year":"2019","journal-title":"Clin Transplant"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0041","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/myc.12704","article-title":"Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis","volume":"61","author":"Hoenigl","year":"2018","journal-title":"Mycoses"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0042","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.7150\/thno.20919","article-title":"Towards Translational ImmunoPET\/MR Imaging of Invasive Pulmonary Aspergillosis: The Humanised Monoclonal Antibody JF5 Detects Aspergillus Lung Infections In Vivo","volume":"7","author":"Davies","year":"2017","journal-title":"Theranostics"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0043","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.3389\/fmicb.2018.01996","article-title":"Pre-clinical Imaging of Invasive Candidiasis Using ImmunoPET\/MR","volume":"9","author":"Morad","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0044","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/COC.0000000000000514","article-title":"Effect of Neutropenic Diet on Infection Rates in Cancer Patients With Neutropenia: A Meta-analysis of Randomized Controlled Trials","volume":"42","author":"Ball","year":"2019","journal-title":"Am J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0045","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.3324\/haematol.2012.062885","article-title":"Variations in non-pharmacological anti-infective measures in childhood leukemia\u2013results of an international survey","volume":"97","author":"Lehrnbecher","year":"2012","journal-title":"Haematologica"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0046","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.ejca.2008.06.022","article-title":"Compliance with anti-infective preventive measures: A multicentre survey among paediatric oncology patients","volume":"44","author":"Lehrnbecher","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0047","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.bbmt.2017.01.073","article-title":"A Multicenter Study of Bacterial Blood Stream Infections in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients: The Role of Acute Gastrointestinal Graft-versus-Host Disease","volume":"23","author":"Satwani","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0048","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1086\/340402","article-title":"Infections caused by viridans streptococci in patients with neutropenia","volume":"34","author":"Tunkel","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0049","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1046\/j.1365-2141.2002.03457.x","article-title":"Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey","volume":"117","author":"Engelhard","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0050","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2141.2007.06601.x","article-title":"Increased risk for invasive pneumococcal diseases in children with acute lymphoblastic leukaemia","volume":"137","author":"Meisel","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0051","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1017\/ice.2018.118","article-title":"Clinical outcome, healthcare cost and length of hospital stay among patients with bloodstream infections and acute leukemia in a cancer center in eastern india","volume":"39","author":"Muennichow","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0052","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/INF.0000000000001938","article-title":"Antibiotic-resistant Gram-negative Blood Stream Infections in Children With Cancer: A Review of Epidemiology, Risk Factors, and Outcome","volume":"37","author":"Levene","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0053","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0054","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1002\/cam4.2395","article-title":"Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials","volume":"8","author":"Egan","year":"2019","journal-title":"Cancer Med"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0055","unstructured":"European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/quinolone-fluoroquinolone-containing-medicinal-products (accessed February 25, 2020) 2019."},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0056","first-page":"2417","article-title":"Bacteria causing bacteremia in pediatric cancer patients presenting with febrile neutropenia\u2013species distribution and susceptibility patterns","volume":"21","author":"Miedema","year":"2013","journal-title":"Support Care Cancer"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0057","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1093\/jac\/dku283","article-title":"Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone","volume":"69","author":"de Lastours","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0058","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.26810","article-title":"Antimicrobial stewardship in paediatric oncology: Impact on optimising gentamicin use in febrile neutropenia","volume":"65","author":"Hennig","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0059","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.ajic.2016.04.229","article-title":"Bacterial bloodstream infections in pediatric allogeneic hematopoietic stem cell recipients before and after implementation of a central line-associated bloodstream infection protocol: A single-center experience","volume":"44","author":"Chang","year":"2016","journal-title":"Am J Infect Control"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0060","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/INF.0000000000001746","article-title":"The North Wind and the Sun: Pediatric Antimicrobial Stewardship Program Combining Restrictive and Persuasive Approaches in Hematology-Oncology Ward and Hematopoietic Stem Cell Transplant Unit","volume":"37","author":"Horikoshi","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0061","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1182\/blood-2007-05-091942","article-title":"Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia","volume":"110","author":"Sung","year":"2007","journal-title":"Blood"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0062","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3389\/fmicb.2019.00681","article-title":"Incidence and Outcome of Invasive Fungal Diseases in Children With Hematological Malignancies and\/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study","volume":"10","author":"Lehrnbecher","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0063","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00010-19","article-title":"Extended Dosing Regimens for Fungal Prophylaxis","volume":"32","author":"Lehrnbecher","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0064","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1212\/WNL.0000000000000570","article-title":"Utility and safety of rituximab in pediatric autoimmune and inflammatory CNS disease","volume":"83","author":"Dale","year":"2014","journal-title":"Neurology"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0065","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/acr.20279","article-title":"Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis","volume":"62","author":"Hugle","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0066","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1007\/s00467-013-2485-9","article-title":"Fulminant viral myocarditis after rituximab therapy in pediatric nephrotic syndrome","volume":"28","author":"Sellier-Leclerc","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0067","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1200\/JCO.2016.67.3301","article-title":"Phase I\/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed\/Refractory Acute Lymphoblastic Leukemia","volume":"34","author":"von Stackelberg","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0068","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jdcr.2017.01.017","article-title":"Blinatumomab-associated vasculitis","volume":"3","author":"Liau","year":"2017","journal-title":"JAAD Case Rep"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0069","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1097\/MPH.0000000000000337","article-title":"Imatinib-induced Severe Hepatitis in a 9-Year-old Girl With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia","volume":"37","author":"Suzuki","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0070","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1200\/JCO.2010.30.7231","article-title":"Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium","volume":"29","author":"Aplenc","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0071","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/neuonc\/nou059","article-title":"Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas","volume":"16","author":"Karajannis","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0072","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(13)70095-0","article-title":"Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study","volume":"14","author":"Mosse","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0073","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.1200\/JCO.2002.08.141","article-title":"Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study","volume":"20","author":"Lashford","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2020.02.005_bib0074","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11060-010-0371-x","article-title":"Feasibility study of 21-day-on\/7-day-off temozolomide in children with brain tumors","volume":"103","author":"Ridola","year":"2011","journal-title":"J Neurooncol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775420300051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775420300051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:56:44Z","timestamp":1758805004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775420300051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0093775420300051"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2020.02.005","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances and future directions in the management of the immunocompromised host","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2020.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}